1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Japan Opioids Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Japan Opioids Market
4. Japan Opioids Market by Product
4.1. Morphine
4.1.1. Cancer Pain
4.1.2. Neuropathic Pain
4.1.3. Osteoarthritis Pain
4.1.4. Other
4.2. Codeine
4.3. Fentanyl
4.4. Meperidine
4.5. Methadone
4.6. Others
5. Japan Opioids Market by
Application
5.1. Pain Management
5.2. Cough Supression
5.3. Diarrhea Suppresion
5.4. Others
6. Japan Opioids Market by
Distribution Channels
6.1. Retail Pharmacies
6.2. Hospital Pharmacies
6.3. Online Channels
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1.Drivers
3.2.2.Restraints
3.2.3.Opportunities
3.2.4.Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for Japan Opioids Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in Japan Opioids Market
4. Japan Opioids Market by Product
4.1. Morphine
4.1.1. Cancer Pain
4.1.2. Neuropathic Pain
4.1.3. Osteoarthritis Pain
4.1.4. Other
4.2. Codeine
4.3. Fentanyl
4.4. Meperidine
4.5. Methadone
4.6. Others
5. Japan Opioids Market by
Application
5.1. Pain Management
5.2. Cough Supression
5.3. Diarrhea Suppresion
5.4. Others
6. Japan Opioids Market by
Distribution Channels
6.1. Retail Pharmacies
6.2. Hospital Pharmacies
6.3. Online Channels
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5